- INHIBITING AGENTS FOR BRUTON'S TYROSINE KINASE
-
Provided are compounds of Formula (I), or pharmaceutically acceptable salts thereof, and methods for their use and production.
- -
-
Page/Page column 79; 80
(2020/11/30)
-
- INHIBITING AGENTS FOR BRUTON'S TYROSINE KINASE
-
Provided are compounds of Formula (I), or pharmaceutically acceptable salts thereof, methods for use as Bruton's tyrosine kinase and methods of production.
- -
-
Page/Page column 86
(2019/12/04)
-
- ANDROGEN RECEPTOR ANTAGONISTS AND USES THEREOF
-
Disclosed are substituted thioimidazolidinone compounds and pharmaceutical compositions comprising such compounds. The compounds and compositions can be used for treatment of androgen receptor-associated diseases or disorders, such as prostate cancer, benign prostatic hypertrophy, male hair loss and hypertrichosis.
- -
-
Page/Page column 82
(2012/09/22)
-
- ANDROGEN RECEPTOR ANTAGONISTS AND USES THEREOF
-
The present invention relates to novel substituted thioimidazolidinone compounds and pharmaceutical compositions comprising such compounds for treatment of androgen receptor-associated diseases or disorders, such as prostate cancer, benign prostatic hypertrophy, male hair loss, muscle loss, acne and hirsutism.
- -
-
Page/Page column 60
(2011/04/18)
-
